A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease

Molecular Biology Reports

Volumn 38, Issue 2, 2011, Pages 819-825

  Wang, Lian Sheng ^a   Yan, Jian Jun ^a   Tang, Na Ping ^b   Zhu, Jun ^a   Wang, Yue Song ^c   Wang, Qi Ming ^a   Tang, Jian Jin ^a   Wang, Ming Wei ^a   Jia, En Zhi ^a   Yang, Zhi Jian ^a   Huang, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b National Shanghai Center for New Drug Safety Evaluation and Research   (China)

^c Ma anshan Municipal People's Hospital   (China)

Author keywords

Coronary artery disease; Inflammatory marker; Polymorphism; Visfatin

Indexed keywords

C REACTIVE PROTEIN; CYSTEINE; INTERLEUKIN 6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; THREONINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SEX DIFFERENCE; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ADIPOKINES; AGED; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANGINA;

EID: 79951576171     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0171-6     Document Type: Article

References (29)

1. W Rosamond K Flegal K Furie, et al. 2008 Heart disease and stroke statistics-2008 update: a report from the American Circulation 117 4 e25 e146 10.1161/CIRCULATIONAHA.107.187998 18086926
2. GK Hansson 2005 Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 1685 1695 1:CAS:528:DC%2BD2MXjsFCltrc%3D 10.1056/NEJMra043430 15843671 (Pubitemid 40530235)
3. P Libby W Sasiela 2006 Plaque stabilization: can we turn theory into evidence? Am J Cardiol 98 (11A) 26P 33P 1:CAS:528:DC%2BD2sXivVSjuw%3D%3D 10.1016/j.amjcard.2006.09.017 17126677 (Pubitemid 44779498)
4. B Samal Y Sun G Stearns, et al. 1994 Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol Cell Biol 14 2 1431 1437 1:CAS:528:DyaK2cXhvV2gsbw%3D 8289818
5. K Oki K Yamane N Kamei, et al. 2007 Circulating visfatin level is correlated with inflammation, but not with insulin resistance Clin Endocrinol 67 796 800 1:CAS:528:DC%2BD2sXhtlOhs7vF 10.1111/j.1365-2265.2007.02966.x (Pubitemid 47628470)
6. AR Moschen A Kaser B Enrich, et al. 2007 Visfatin, an adipocytokine with proinflammatory and immunomodulating properties J Immunol 178 1748 1758 1:CAS:528:DC%2BD2sXntVGlsA%3D%3D 17237424 (Pubitemid 46154646)
7. TB Dahl A Yndestad M Skjelland, et al. 2007 Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization Circulation 115 8 972 980 1:CAS:528:DC%2BD2sXhvVyquro%3D 10.1161/CIRCULATIONAHA.106.665893 17283255 (Pubitemid 46328290)
8. SW Liu SB Qiao JS Yuan DQ Liu 2009 Association of plasma visfatin levels with inflammation, atherosclerosis, and acute coronary syndromes in humans Clin Endocrinol 71 2 202 207 1:CAS:528:DC%2BD1MXhtVSqt7bO 10.1111/j.1365-2265.2008. 03453.x
9. YY Zhang L Gottardo R Thompson, et al. 2006 A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes Obesity 14 2119 2126 1:CAS:528:DC%2BD2sXhtFyrtr8%3D 10.1038/oby.2006.247 17189536 (Pubitemid 46121965)
10. SQ Ye BA Simon JP Maloney, et al. 2005 Pre-B-cell colony enhancing factor as a potential novel biomarker in acute lung injury Am J Respir Crit Care Med 171 361 370 10.1164/rccm.200404-563OC 15579727 (Pubitemid 40223404)
11. A Tokunaga A Miura Y Okauchi, et al. 2008 The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects Endocr J 55 205 212 1:CAS:528:DC%2BD1cXmtFKjsr0%3D 10.1507/endocrj.K07E-039 18270432 (Pubitemid 351520199)
12. WX Jian TH Luo YY Gu, et al. 2006 The visfatin gene is associated with glucose and lipid metabolism in a Chinese population Diabet Med 23 967 973 1:CAS:528:DC%2BD28XhtFSjs7vL 10.1111/j.1464-5491.2006.01909.x 16922702 (Pubitemid 44257940)
13. JJ Yan NP Tang JJ Tang, et al. 2010 Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population Clin Chim Acta 411 (1-2) 26 30 1:CAS:528:DC%2BD1MXhsVGrtbzM 10.1016/j.cca.2009.09.033 19804767
14. WP Santamore FR Kahl MA Kutcher, et al. 1988 A microcomputer based automated, quantitative coronary angiographic analysis system Ann Biomed Eng 16 367 377 1:STN:280:DyaL1M%2FisVWisA%3D%3D 10.1007/BF02364624 3177983
15. S Ehara Y Kobayashi M Yoshiyama, et al. 2004 Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study Circulation 110 22 3424 3429 10.1161/01.CIR. 0000148131.41425.E9 15557374 (Pubitemid 39602220)
16. B Wang J Pan L Wang, et al. 2006 Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease Atherosclerosis 184 425 430 1:CAS:528: DC%2BD28XhsFCrtA%3D%3D 10.1016/j.atherosclerosis.2005.05.008 15996671 (Pubitemid 43049730)
17. Z Chen Q Qian G Ma J Wang, et al. 2009 A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease Mol Biol Rep 36 5 889 893 1:CAS:528:DC%2BD1MXjvFaqur4%3D 10.1007/s11033-008-9259-7 18459066
18. J Bressler AR Folsom DJ Couper, et al. 2010 Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study Am J Epidemiol. 171 1 14 23 10.1093/aje/kwp377 19955471
19. D Pasalić N Marinković B Grsković, et al. 2009 C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease Mol Biol Rep 36 4 775 780 10.1007/s11033-008-9244-1 18401567
20. AR Lucas R Korol CJ Pepine 2006 Inflammation in atherosclerosis: some thoughts about acute coronary syndromes Circulation 113 17 e728 e732 1:CAS:528:DC%2BD28Xks1ans7Y%3D 10.1161/CIRCULATIONAHA.105.601492 16651475
21. A Fukuhara M Matsuda M Nishizawa, et al. 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 426 430 1:CAS:528:DC%2BD2MXksFyitw%3D%3D 10.1126/science.1097243 15604363 (Pubitemid 40139988)
22. S Ognjanovic S Bao SY Yamamoto, et al. 2001 Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and experssion in human fetal membranes J Mol Endocrinol 26 2 107 117 1:CAS:528:DC%2BD3MXis1Kls74%3D 10.1677/jme.0.0260107 11241162 (Pubitemid 32266186)
23. S Ognjanovic GD Bryant-Greenwood 2002 Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes Am J Obstet Gynecol 187 4 1051 1058 1:CAS:528:DC%2BD38XovVCktbs%3D 10.1067/mob.2002.126295 12389004 (Pubitemid 35178410)
24. R Adya BK Tan A Punn J Chen HS Randeva 2008 Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis Cardiovasc Res 78 2 356 365 1:CAS:528:DC%2BD1cXmt1Wru7w%3D 10.1093/cvr/cvm111 18093986 (Pubitemid 351556097)
25. K Mizuno K Satomura A Miyamoto, et al. 1992 Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes N Engl J Med 326 5 287 291 1:STN:280:DyaK387gtVWnsw%3D%3D 10.1056/NEJM199201303260502 1728732
26. V Fuster L Badimon JJ Badimon, et al. 1992 The pathologenesis of coronary artery disease and the acute coronary syndrome N Engl J Med 326 4 242 250 1:STN:280:DyaK38%2FptlSgtg%3D%3D 10.1056/NEJM199201233260406 1727977
27. MK Kuhlmann M Yoshino NW Levin 2004 Differences in cardiovascular mortality rates among hemodialysis patients in the United States and Japan: the importance of background cardiovascular mortality Hemodial Int 8 4 394 399 10.1111/j.1492-7535.2004.80416.x 19379447 (Pubitemid 40932793)
28. PE Morange DA Tregouet T Godefroy, et al. 2008 Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study J Mol Med 86 10 1153 1161 1:CAS:528:DC%2BD1cXhtFCgurfO 10.1007/s00109-008-0375-6 18600307
29. P Liu H Li J Cepeda, et al. 2009 Critical role of PBEF expression in pulmonary cell inflammation and permeability Cell Biol Int 33 1 19 30 1:CAS:528:DC%2BD1cXhsFagsb%2FM 10.1016/j.cellbi.2008.10.015 18996492